Matching-Adjusted Indirect Comparison (MAIC): Entrectinib versus Crizotinib in Asian Patients with ROS1+NSCLC

被引：0
|
作者：
Lu, S. [1 ]
Fan, Y. [2 ]
Yu, Y. [3 ]
Dong, X. [4 ]
Li, J. [5 ]
Zhao, J. [6 ]
Tao, S. [7 ]
Chen, M. [7 ]
Chen, Y. [7 ]
Liu, Y. [7 ]
Xu, J. [7 ]
Hu, X. [8 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai, Peoples R China
[2] Zhejiang Canc Hosp, Hangzhou, Peoples R China
[3] Dept Med Oncol, Harbin, Peoples R China
[4] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China
[5] Sichuan Canc Hosp, Chengdu, Peoples R China
[6] Peking Univ Canc Hosp & Inst, Beijing, Peoples R China
[7] Shanghai Roche Pharmaceut Ltd, Shanghai, Peoples R China
[8] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
ROS1+NSCLC; Asian patients; Matching-Adjusted Indirect Comparison;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP12.02-12
引用
收藏
页码：S679 / S679
页数：1
相关论文
共 50 条
  • [31] Effectiveness of Radiofrequency Catheter Ablation Using Ablation Index Versus Second Generation Cryoballoon in the Treatment of Persistent Atrial Fibrillation: A Matching-Adjusted Indirect Comparison
    Ahmed Hussein
    Giuseppe Stabile
    Kaitlyn Dawkins
    Paul Spin
    Laura Goldstein
    Tom Wei
    Maria Velleca
    Leena Patel
    Dhiraj Gupta
    Advances in Therapy, 2021, 38 : 4388 - 4402
  • [32] Effectiveness of Radiofrequency Catheter Ablation Using Ablation Index Versus Second Generation Cryoballoon in the Treatment of Persistent Atrial Fibrillation: A Matching-Adjusted Indirect Comparison
    Hussein, Ahmed
    Stabile, Giuseppe
    Dawkins, Kaitlyn
    Spin, Paul
    Goldstein, Laura
    Wei, Tom
    Velleca, Maria
    Patel, Leena
    Gupta, Dhiraj
    ADVANCES IN THERAPY, 2021, 38 (08) : 4388 - 4402
  • [33] Matching-adjusted indirect comparison of palbociclib versus ribociclib and abemaciclib in hormone receptor-positive/HER2-negative advanced breast cancer
    Rugo, Hope S.
    Haltner, Anja
    Zhan, Lin
    Tran, Anh
    Bananis, Eustratios
    Hooper, Becky
    Mitra, Debanjali
    Cameron, Chris
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (06) : 457 - 467
  • [34] Loncastuximab Tesirine Versus Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory DLBCL After ≥ 2 Lines of Therapy: Matching-Adjusted Indirect Comparison
    Wilson, Koo
    Chiodi, Francesca
    Paine, Abby
    Hakimi, Zalmai
    Ward, Victoria
    Macmillan, Tom
    Eriksson, Daniel
    Mappa, Silvia
    ADVANCES IN THERAPY, 2025, : 2445 - 2464
  • [35] The effects of different schedules of bortezomib, melphalan, and prednisone for patients with newly diagnosed multiple myeloma who are transplant ineligible: a matching-adjusted indirect comparison
    Mateos, Maria-Victoria
    San-Miguel, Jesus
    Goldschmidt, Hartmut
    Sonneveld, Pieter
    Dimopoulos, Meletios A.
    Heeg, Bart
    Hashim, Mahmoud
    Deraedt, William
    Hu, Peter
    Lam, Annette
    He, Jianming
    LEUKEMIA & LYMPHOMA, 2020, 61 (03) : 680 - 690
  • [36] Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis
    Rand, Kim
    Ramos-Goni, Juan Manuel
    Akmaz, Bulent
    Sole-Feu, Laia
    Armario-Hita, Jose-Carlos
    DERMATOLOGY AND THERAPY, 2024, 14 (01) : 169 - 182
  • [37] Matching-adjusted indirect comparison and cost-effectiveness of mitoxantrone hydrochloride liposome versus Chidamide in relapsed or refractory peripheral T-cell lymphoma in China
    Liu, Ying
    He, Xiaoning
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2025,
  • [38] Matching-adjusted indirect comparison of guselkumab versus risankizumab in patients with moderate-to-severe plaque psoriasis: Change in baseline Psoriasis Area and Severity Index from week 4 to 40
    Langley, Richard G.
    Sanyal, Chiranjeev
    Situ, Aaron
    Alulis, Sarah
    Hassan, Fareen
    Peterson, Steve
    Teneralli, Rachel E.
    Lee, Jennifer
    Patel, Barkha P.
    Disher, Tim
    JAAD INTERNATIONAL, 2024, 15 : 165 - 167
  • [39] Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis
    Kim Rand
    Juan Manuel Ramos-Goñi
    Bülent Akmaz
    Laia Solé-Feu
    José-Carlos Armario-Hita
    Dermatology and Therapy, 2024, 14 : 169 - 182
  • [40] Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT
    Stolz, Daiana
    Hermansson, Erik
    Ouwens, Mario
    Singh, Barinder
    Sharma, Akanksha
    Jackson, Dan
    Darken, Patrick
    Marshall, Jonathan
    Bowen, Karin
    Muellerova, Hana
    Navarrete, Bernardino Alcazar
    Russell, Richard
    Han, MeiLan K.
    Tansey-Dwyer, Deniz
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (10) : 1395 - 1405
12345